http://www.nycomed.com/privacy-policy/2012-02-13http://www.nycomed.com/about-nycomed/2012-03-14http://www.nycomed.com/about-nycomed/nycomed-acquisition/2012-03-14http://www.nycomed.com/about-nycomed/our-culture-and-values/2012-03-14http://www.nycomed.com/about-nycomed/corporate-responsibility/2012-03-14http://www.nycomed.com/about-nycomed/nycomed-worldwide/2012-03-14http://www.nycomed.com/about-nycomed/nycomed-worldwide/europe/2012-04-05http://www.nycomed.com/about-nycomed/nycomed-worldwide/russia and cis/2012-03-14http://www.nycomed.com/about-nycomed/nycomed-worldwide/americas/2012-03-22http://www.nycomed.com/about-nycomed/nycomed-worldwide/asia-pacific/2012-04-18http://www.nycomed.com/about-nycomed/nycomed-worldwide/africa and middle east/2012-03-14http://www.nycomed.com/partnerships/2012-02-14http://www.nycomed.com/partnerships/partnering-with-nycomed/2010-12-08http://www.nycomed.com/partnerships/what-we-bring-to-the-partnership/2011-01-20http://www.nycomed.com/partnerships/what-we-are-looking-for/2010-10-18http://www.nycomed.com/partnerships/our-partnerships/2011-01-20http://www.nycomed.com/partnerships/our-partnerships/licensing/2011-08-23http://www.nycomed.com/partnerships/our-partnerships/mergersacquisitions/2011-12-12http://www.nycomed.com/partnerships/events/2012-03-22http://www.nycomed.com/rd/2011-10-25http://www.nycomed.com/rd/our-model/2011-10-25http://www.nycomed.com/rd/pipeline/2011-06-07http://www.nycomed.com/rd/pipeline/registration/2011-06-06http://www.nycomed.com/rd/pipeline/phase3/2011-06-06http://www.nycomed.com/rd/pipeline/phase2/2010-09-28http://www.nycomed.com/rd/pipeline/phase1/2011-03-02http://www.nycomed.com/rd/clinical-trials/2011-08-09http://www.nycomed.com/products/2011-10-25http://www.nycomed.com/products/gastroenterology/2011-10-25http://www.nycomed.com/products/gastroenterology/pantoprazole/2011-06-24http://www.nycomed.com/products/gastroenterology/eparema/2010-09-28http://www.nycomed.com/products/gastroenterology/riopan/2011-06-07http://www.nycomed.com/products/gastroenterology/hepatalgina/2010-09-28http://www.nycomed.com/products/respiratory/2011-10-25http://www.nycomed.com/products/respiratory/daxas/2011-06-10http://www.nycomed.com/products/respiratory/alvesco/2011-06-24http://www.nycomed.com/products/respiratory/omnaris/2011-08-23http://www.nycomed.com/products/respiratory/curosurf/2010-09-28http://www.nycomed.com/products/respiratory/zymelin_xymelin/2010-09-28http://www.nycomed.com/products/respiratory/febrisan/2010-09-28http://www.nycomed.com/products/respiratory/amol/2010-09-28http://www.nycomed.com/products/pain-management/2010-09-28http://www.nycomed.com/products/pain-management/matrifen/2010-09-28http://www.nycomed.com/products/pain-management/neosaldina/2010-09-28http://www.nycomed.com/products/pain-management/xefo/2010-09-28http://www.nycomed.com/products/pain-management/instanyl/2011-07-06http://www.nycomed.com/products/pain-management/ibumetin/2011-06-07http://www.nycomed.com/products/osteoporosis/2011-10-25http://www.nycomed.com/products/osteoporosis/calcium/2010-09-28http://www.nycomed.com/products/osteoporosis/preotact/2011-06-24http://www.nycomed.com/products/tissue-management/2011-10-25http://www.nycomed.com/products/tissue-management/tachosil/2011-06-24http://www.nycomed.com/products/further-therapies/2010-09-28http://www.nycomed.com/products/further-therapies/actovegin/2010-09-28http://www.nycomed.com/products/further-therapies/circadin/2011-06-24http://www.nycomed.com/manufacturing/2012-01-16http://www.nycomed.com/manufacturing/global-contract-manufacturing/2011-10-25http://www.nycomed.com/manufacturing/global-contract-manufacturing/technologies/2011-01-20http://www.nycomed.com/manufacturing/global-contract-manufacturing/technologies/solids/2011-10-25http://www.nycomed.com/manufacturing/global-contract-manufacturing/technologies/semi-solids/2011-10-25http://www.nycomed.com/manufacturing/global-contract-manufacturing/technologies/non-sterile liquids/2011-10-25http://www.nycomed.com/manufacturing/global-contract-manufacturing/technologies/steriles/2011-10-25http://www.nycomed.com/manufacturing/global-contract-manufacturing/service-portfolio/2011-01-20http://www.nycomed.com/manufacturing/global-contract-manufacturing/service-portfolio/packaging/2011-10-25http://www.nycomed.com/manufacturing/global-contract-manufacturing/service-portfolio/development/2011-10-25http://www.nycomed.com/manufacturing/global-contract-manufacturing/operational-excellence/2010-12-10http://www.nycomed.com/manufacturing/global presence/2012-01-16http://www.nycomed.com/manufacturing/events/2011-10-28http://www.nycomed.com/media/2011-10-25http://www.nycomed.com/media/news-releases/2011-05-04http://www.nycomed.com/media/news-releases/2010/2010-12-08http://www.nycomed.com/media/news-releases/2010/20100921-effrx-nycomed-us/2011-01-20http://www.nycomed.com/media/news-releases/2010/daxas-roflumilast-data-analysis-shows-reduction-in-harmful-lung-attacks/2011-01-20http://www.nycomed.com/media/news-releases/2010/from-oranienburg-to-the-rest-of-the-world---global-market-launch-of-daxas/2011-01-31http://www.nycomed.com/media/news-releases/2010/ge healthcare and nycomed to form joint venture/2011-01-20http://www.nycomed.com/media/news-releases/2010/jury renders positive findings on us pantoprazole protonix patent/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomed and baxter/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomed and forest laboratories receive complete fda response letter for roflumilast/2010-11-26http://www.nycomed.com/media/news-releases/2010/nycomed and merck co inc announce commercialization agreements for daxas in europe and canada/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomed novel anti-inflammatory therapy/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomed on track in 2009/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomed-achieved-significant-milestone-in-second-quarter-2010/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomed-is-keeping-the-pace-in-third-quarter-2010/2010-12-08http://www.nycomed.com/media/news-releases/2010/nycomeds first quarter 2010 results confirm the direction/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomeds novel anti-inflammatory therapy daxas receives marketing authorisation in eu/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomeds us patent for protonix pantoprazole valid/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomeds-us-partner-forest-laboratories-responds-to-fda-complete-response-letter/2011-01-20http://www.nycomed.com/media/news-releases/2010/nycomed-to-accelerate-expansion-in-china/2011-02-03http://www.nycomed.com/media/news-releases/2010/zydus-nycomed-commissions-the-newly-expanded-api-manufactoring-facility-at-navi-mumbai/2010-11-26http://www.nycomed.com/media/news-releases/2009/2010-12-08http://www.nycomed.com/media/news-releases/2009/a satisfactory 2008 for nycomed/2010-09-30http://www.nycomed.com/media/news-releases/2009/expanded indication for nycomeds tachosil/2010-09-30http://www.nycomed.com/media/news-releases/2009/four studies published in the lancet show roflumilast daxas/2010-09-30http://www.nycomed.com/media/news-releases/2009/largest asthma survey shows disease is not controlled in majority of children/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed and forest laboratories to collaborate on us commercialisation of daxas in copd/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed announces fda filing for daxas in copd/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed files european marketing authorisation application for daxas in copd/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed receives marketing authorization for pantoprazole 20mg/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed reports a solid start to 2009/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed reports continued satisfactory performance/2011-01-20http://www.nycomed.com/media/news-releases/2009/nycomed reports sustained momentum in second quarter 2009/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed strengthens its osteoporosis portfolio/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomed sustains commitment to russia-cis and invests in new pharmaceutical production plant/2011-01-20http://www.nycomed.com/media/news-releases/2009/nycomed to acquire local portfolio from sanofi-aventis and zentiva/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomeds instanyl is first intranasal fentanyl approved in europe/2010-09-30http://www.nycomed.com/media/news-releases/2009/nycomeds instanyl receives positive chmp opinion/2010-09-29http://www.nycomed.com/media/news-releases/2009/positive chmp opinion for pantoprazole 20mg otc will give pharmacists first line treatment/2010-09-29http://www.nycomed.com/media/news-releases/2009/roflumilast a novel once-a-day tablet for copd reduces exacerbations and improves lung function/2010-09-29http://www.nycomed.com/media/news-releases/2008/2010-12-08http://www.nycomed.com/media/news-releases/2008/a promising start into 2008/2010-09-29http://www.nycomed.com/media/news-releases/2008/a successful 2007 paves the way for future of nycomed/2010-09-29http://www.nycomed.com/media/news-releases/2008/acquisition of bradley pharmaceuticals successfully closed/2010-09-29http://www.nycomed.com/media/news-releases/2008/alvesco gains fda approval for the us market/2010-09-29http://www.nycomed.com/media/news-releases/2008/guido oelkers joins nycomed executive committee/2010-09-29http://www.nycomed.com/media/news-releases/2008/michael kuner joins nycomed executive committee/2010-09-29http://www.nycomed.com/media/news-releases/2008/moving ahead strong results in second quarter 2008/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed adds veltuzumab for autoimmune diseases to r and d pipeline/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed and wyeth announce launch of an own generic version of protonix/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed confirms positive trend in third quarter 2008/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed extends geographic reach to venezuela/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed intends to move chemical production to indian joint venture/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed optimises its european manufacturing network/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed sells oncology programs to 4sc/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomed successfully closes oncology program/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomeds ciclesonide to be commercialised in the united states by sepracor/2010-09-29http://www.nycomed.com/media/news-releases/2008/nycomeds daxas shows encouraging preliminary results/2010-09-29http://www.nycomed.com/media/news-releases/2008/tachosil to be marketed in the unites states by baxter/2010-09-29http://www.nycomed.com/media/news-releases/2011/2011-01-05http://www.nycomed.com/media/news-releases/2011/daxas---roflumilast---included-as-a-new-treatment-option-in-latest-international-copd-guidelines/2011-04-08http://www.nycomed.com/media/news-releases/2011/fda-accepts-filling-of-nda-for-ciclesonide-hfa-nasal-aerosol/2011-07-08http://www.nycomed.com/media/news-releases/2011/instanyl-receives-european-approval/2011-07-08http://www.nycomed.com/media/news-releases/2011/new-data-analysis-supports-the-use-of-daxas/2011-09-26http://www.nycomed.com/media/news-releases/2011/nycomed-acquires-distribution-rights-to-product-portfolio-in-turkey/2011-07-08http://www.nycomed.com/media/news-releases/2011/nycomed-and-almirall-announce-a-licensing-agreement-for-ebastine/2011-09-30http://www.nycomed.com/media/news-releases/2011/nycomed-and-almirall-announce-commercialization-agreement-for-roflumilast-in-spain/2011-07-08http://www.nycomed.com/media/news-releases/2011/nycomed-and-norgine-sign-a-licence-agreement-for-moviprep/2011-08-22http://www.nycomed.com/media/news-releases/2011/nycomed-and-orion-corporation-to-collaborate-on-easyhaler-for-asthma-and-copd/2011-08-04http://www.nycomed.com/media/news-releases/2011/nycomed-announces-agreement-with-eurand-for-zenpep-in-russia-cis/2011-04-08http://www.nycomed.com/media/news-releases/2011/nycomed-announces-react-study-to-evaluate-impact-of-daxas---roflumilast/2011-07-08http://www.nycomed.com/media/news-releases/2011/nycomed-continues-to-outperform-in-emerging-markets-in-first-quarter-2011/2011-07-08http://www.nycomed.com/media/news-releases/2011/nycomed-reports-double-digit-growth-across-emerging-markets-in-second-quarter-2011/2011-08-17http://www.nycomed.com/media/news-releases/2011/nycomeds-novel-copd-therapy-roflumilast-receives-fda-approval/2011-04-08http://www.nycomed.com/media/news-releases/2011/nycomed-submits-european-marketing-authorisation-application-for-teduglutide---revestive/2011-07-08http://www.nycomed.com/media/news-releases/2011/nycomed-to-acquire-colombian-company-farmacol/2011-02-04http://www.nycomed.com/media/news-releases/2011/nycomed-to-market-roches-osteoporosis-treatment-bonviva-in-key-asia-pacific-markets/2011-07-08http://www.nycomed.com/media/news-releases/2011/nycomed-well-positioned-in-emerging-markets/2011-04-08http://www.nycomed.com/media/news-releases/2011/steovess-accepted-for-national-approvals-in-european-union/2011-12-20http://www.nycomed.com/media/news-releases/2011/takeda-and-msd-mutually-agree-to-end-co-promotion-agreement-for-daxas/2011-12-22http://www.nycomed.com/media/news-releases/2011/takeda-appoints-jostein-davidsen-head-of-emerging-markets/2011-10-17http://www.nycomed.com/media/news-releases/2011/takeda-completes-acquisition-and-names-new-ceo-of-nycomed/2011-09-30http://www.nycomed.com/media/news-releases/2011/takeda-to-acquire-nycomed/2011-07-08http://www.nycomed.com/media/news-releases/2012/2012-01-10http://www.nycomed.com/media/news-releases/2012/takeda-announces-strategic-measures-to-achieve-efficiencies-for-long-term-growth/2012-01-18http://www.nycomed.com/media/news-releases/2007/2010-12-08http://www.nycomed.com/media/news-releases/2007/acuity one-year findings meet all primary endpoints in favour of angiox/2010-09-29http://www.nycomed.com/media/news-releases/2007/alvesco product rights in the us return to nycomed/2010-09-29http://www.nycomed.com/media/news-releases/2007/denmark roskilde/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed and nps pharmaceuticals announce licensing agreement for gattex/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed and wyeth continue lawsuit to defend patent for pantoprazole/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed announces integration programme/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed annual results 2006/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed expands preotact deal/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed files marketing authorisation application for an intranasal fentanyl spray in europe/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed h1 results 2007/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed headquarters established in zurich switzerland/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed officially launched as combined group/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed q1 results 2007/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed significantly increases profitability/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed signs definitive agreement to acquire bradley pharmaceuticals/2010-09-29http://www.nycomed.com/media/news-releases/2007/nycomed to market circadin for primary insomnia/2010-09-29http://www.nycomed.com/media/news-releases/2007/us court takes matter of motion for preliminary injunction for protonix under advisement/2010-09-29http://www.nycomed.com/media/news-releases/2007/venticute granted fast track designation in the us/2010-09-29http://www.nycomed.com/media/news-releases/2006/executive vice president research and development appointed/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomed acquires romanian pharmaceutical company/2010-09-30http://www.nycomed.com/media/news-releases/2006/nycomed and durect corporation announce licensing agreement on posidur/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomed announces offer to purchase senior notes/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomed commences bank syndication process/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomed interim results first half 2006/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomed interim results q3 2006/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomed receives eu and us antitrust clearances for the acquisition of altana pharma/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomed to acquire altana pharma/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomeds acquisition of altana pharma approved/2010-09-29http://www.nycomed.com/media/news-releases/2006/nycomeds purchase of altana pharma ag completed/2010-09-29http://www.nycomed.com/media/news-releases/2006/the new nycomed executive committee appointed/2010-09-29http://www.nycomed.com/media/media-resources/2011-12-06http://www.nycomed.com/media/media-resources/publications/2012-02-15http://www.nycomed.com/media/newsletter/2011-06-07http://www.nycomed.com/media/daxas/contactdaxas/confirmationpage/2010-06-25http://www.nycomed.com/media/daxas/contactdaxas/contacterror/2010-06-25http://www.nycomed.com/career/2012-02-15http://www.nycomed.com/career/who-we-are/2012-02-15http://www.nycomed.com/career/what-we-are-looking-for/2012-02-15http://www.nycomed.com/career/what-we-offer/2011-10-25http://www.nycomed.com/career/what-we-offer/compensation-and-benefits/2012-02-15http://www.nycomed.com/career/what-we-offer/career-development/2012-02-15http://www.nycomed.com/career/joining-us/2012-02-15http://www.nycomed.com/sitemap/2010-04-14http://www.nycomed.com/search/2010-12-20http://www.nycomed.com/contact/2012-03-14http://www.nycomed.com/terms-of-use/2011-02-01http://www.nycomed.com/downloads/order-nycomed-publications/2012-02-15http://www.nycomed.com/my-account/activate-account/2010-10-08http://www.nycomed.com/my-account/forgot-password/2010-10-08http://www.nycomed.com/my-account/inform-password-renewal/2010-12-08http://www.nycomed.com/my-account/renew-password/2010-12-08http://www.nycomed.com/my-account/sign-up/2010-10-08http://www.nycomed.com/my-account/login/2010-12-08